Walgreens Boots Alliance, Inc. (WBA), an integrated healthcare, pharmacy, and retail leader, beat revenue analyst expectations for its fiscal 2023 third quarter. The company reported a revenue of $35.42 billion, above the consensus revenue estimate of $34.12 billion and up 8.6% year-over-year due to sales growth in its retail pharmacy and healthcare segments.
WBA’s U.S. retail pharmacy segment generated around $28 billion in sales for the quarter, an increase of 4.4% year-over-year. Also, its pharmacy sales grew 6.3% compared to the same quarter of 2022. However, the company posted an adjusted earnings per share of $1 versus $1.07 expected by analysts.
